back to cluster viewer
cluster path 0001111111111
46 words, 5,472 tokens
freq alpha suffix
Words in frequency order
1 | advantage | 5,268
|
2 | endophenotype | 55
|
3 | precedence | 45
|
4 | excesses | 35
|
5 | overprediction | 7
|
6 | ulnae | 6
|
7 | drifts | 5
|
8 | consensuses | 4
|
9 | ssi-rate | 3
|
10 | temperature-memory | 3
|
11 | ctg.comparison | 2
|
12 | enantio-purity | 2
|
13 | hffs | 2
|
14 | oestrogenicity | 2
|
15 | stereochemistries | 2
|
16 | 2327492 | 1
|
17 | actrim | 1
|
18 | ante-colically | 1
|
19 | benefit.it | 1
|
20 | consume-reduction | 1
|
21 | ct-evidence | 1
|
22 | curce | 1
|
23 | data.interval | 1
|
24 | difference-corresponding | 1
|
25 | difference.none | 1
|
26 | dose-resulted | 1
|
27 | hairlines | 1
|
28 | hrt.it | 1
|
29 | inkling | 1
|
30 | interface-lattice | 1
|
31 | latero-laterally | 1
|
32 | markers-urinary | 1
|
33 | neuroradiology/society | 1
|
34 | nurse-time | 1
|
35 | oxyalkyl | 1
|
36 | preponderence | 1
|
37 | progrand | 1
|
38 | recannalisation | 1
|
39 | relowering | 1
|
40 | spin-out | 1
|
41 | survival-advantage | 1
|
42 | targets.out | 1
|
43 | tbcl3 | 1
|
44 | transfer-effects | 1
|
45 | treatment/standard | 1
|
46 | tunel-positivity | 1
|
Words in alphabetical order
1 | 2327492 | 1
|
2 | actrim | 1
|
3 | advantage | 5,268
|
4 | ante-colically | 1
|
5 | benefit.it | 1
|
6 | consensuses | 4
|
7 | consume-reduction | 1
|
8 | ct-evidence | 1
|
9 | ctg.comparison | 2
|
10 | curce | 1
|
11 | data.interval | 1
|
12 | difference-corresponding | 1
|
13 | difference.none | 1
|
14 | dose-resulted | 1
|
15 | drifts | 5
|
16 | enantio-purity | 2
|
17 | endophenotype | 55
|
18 | excesses | 35
|
19 | hairlines | 1
|
20 | hffs | 2
|
21 | hrt.it | 1
|
22 | inkling | 1
|
23 | interface-lattice | 1
|
24 | latero-laterally | 1
|
25 | markers-urinary | 1
|
26 | neuroradiology/society | 1
|
27 | nurse-time | 1
|
28 | oestrogenicity | 2
|
29 | overprediction | 7
|
30 | oxyalkyl | 1
|
31 | precedence | 45
|
32 | preponderence | 1
|
33 | progrand | 1
|
34 | recannalisation | 1
|
35 | relowering | 1
|
36 | spin-out | 1
|
37 | ssi-rate | 3
|
38 | stereochemistries | 2
|
39 | survival-advantage | 1
|
40 | targets.out | 1
|
41 | tbcl3 | 1
|
42 | temperature-memory | 3
|
43 | transfer-effects | 1
|
44 | treatment/standard | 1
|
45 | tunel-positivity | 1
|
46 | ulnae | 6
|
Words in suffix order
1 | 2327492 | 1
|
2 | tbcl3 | 1
|
3 | dose-resulted | 1
|
4 | progrand | 1
|
5 | treatment/standard | 1
|
6 | ulnae | 6
|
7 | interface-lattice | 1
|
8 | precedence | 45
|
9 | ct-evidence | 1
|
10 | preponderence | 1
|
11 | curce | 1
|
12 | advantage | 5,268
|
13 | survival-advantage | 1
|
14 | nurse-time | 1
|
15 | difference.none | 1
|
16 | endophenotype | 55
|
17 | ssi-rate | 3
|
18 | difference-corresponding | 1
|
19 | inkling | 1
|
20 | relowering | 1
|
21 | data.interval | 1
|
22 | oxyalkyl | 1
|
23 | actrim | 1
|
24 | recannalisation | 1
|
25 | overprediction | 7
|
26 | consume-reduction | 1
|
27 | ctg.comparison | 2
|
28 | stereochemistries | 2
|
29 | hairlines | 1
|
30 | excesses | 35
|
31 | consensuses | 4
|
32 | hffs | 2
|
33 | transfer-effects | 1
|
34 | drifts | 5
|
35 | benefit.it | 1
|
36 | hrt.it | 1
|
37 | spin-out | 1
|
38 | targets.out | 1
|
39 | ante-colically | 1
|
40 | latero-laterally | 1
|
41 | markers-urinary | 1
|
42 | temperature-memory | 3
|
43 | neuroradiology/society | 1
|
44 | oestrogenicity | 2
|
45 | enantio-purity | 2
|
46 | tunel-positivity | 1
|